CRRTFCrescita Therapeutics Inc

About Crescita Therapeutics Inc (CRRTF)

Crescita Therapeutics Inc (CRRTF) is a Drug Manufacturers - Specialty & Generic company headquartered in Laval, QC, Canada whose shares trade over-the-counter on the Pink tier.

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

CRRTF key facts

Ticker symbol

CRRTF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Laval, QC, Canada

Country of incorporation

CA

Year of incorporation

2016

Estimated market cap

$7.42M (as of May 9, 2025)

Shares outstanding

19,028,220

Reporting standard

International Reporting: Toronto Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Crescita Therapeutics Inc leadership

• Serge Verreault — CEO, President
• Jose DaRocha — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with C